Predictive Risk Factors and Online Nomograms for Synchronous Colon Cancer With Liver Metastasis

Ya-Juan Zhu; Ye Chen; Hao-Yue Hu; Yu-Wen Zhou; Yue-Ting Zhu; Ji-Yan Liu

doi:10.3389/fonc.2020.01681

Predictive Risk Factors and Online Nomograms for Synchronous Colon Cancer With Liver Metastasis

Front Oncol. 2020 Oct 2:10:1681. doi: 10.3389/fonc.2020.01681. eCollection 2020.

Authors

Ya-Juan Zhu¹, Ye Chen², Hao-Yue Hu³, Yu-Wen Zhou¹, Yue-Ting Zhu¹, Ji-Yan Liu^{1

4}

Affiliations

¹ Department of Biotherapy, Cancer Center, and National Clinical Research Center for Geriatrics, West China Hospital, West China Medical School, Sichuan University, Chengdu, China.
² Department of Abdominal Cancer, Cancer Center, West China Hospital, West China Medical School, Sichuan University, Chengdu, China.
³ Lung Cancer Center, Cancer Center, West China Hospital, West China Medical School, Sichuan University, Chengdu, China.
⁴ Department of Oncology, The First People's Hospital of Ziyang, Ziyang, China.

Abstract

Objectives: To develop and validate predictive nomograms of cancer specific survival (CSS) and overall survival (OS) for synchronous colon cancer with liver metastasis (SCLM) patients.

Methods: Patients with pathologically diagnosed colon cancer with liver metastasis were retrieved from the SEER database between 2010 and 2015. Only SCLM patients were included. Univariate and multivariate cox regression analyses were conducted to identify the potential predictors of patients' survival outcomes. The selected variables were integrated to create predictive nomograms via R tools. Furthermore, the concordance index Harrell's C statistic (C-index) was calculated to describe the discrimination of nomograms. Calibration (1000 bootstrap resamples) curves were plotted to compare the predictions of nomograms with the observed outcomes. Decision curve analysis (DCA) and clinical impact curves were performed to evaluate the clinical effects of nomograms.

Results: A total of 22,378 SCLM patients were included. The median time of OS and CSS was 13 and 17 months, respectively. The 1-, 2-, and 3-year rate of OS was 50.6, 28.1, and 14.8%, respectively. While the 1-, 2-, and 3-year rate of CSS was 58.7, 36.8, and 22.5%, respectively. SCLM patients with increased age, left primary tumor location, AJCC IVb stage, and no chemotherapy were associated with an obviously reduced OS and CSS. Variables including age, histological grade, T/N/M stage, tumor size, bone/lung metastasis, CEA, surgery of primary site, and chemotherapy were closely related to the prognoses of SCLM patients. Nomograms of OS and CSS were built and displayed online for convenient utilization. The C-index of OS and CSS monograms were 0.74 and 0.73, respectively, indicating relatively good discrimination of the nomograms. The calibration curves suggested a good agreement between the actual observation and the nomogram prediction. DCAs and clinical impact curves reflected favorable potential clinical effects of predictive nomograms.

Conclusion: Chemotherapy, surgery of primary site, and age were important independent risk factors for the CSS and OS of SCLM patients. We built and validated two reliable nomograms of OS and CSS to predict the prognoses of SCLM patients, which can be accessed online at (https://predictive-tool.shinyapps.io/CSS-DynNomapp/; https://predictive-tool.shinyapps.io/OS-DynNomapp/).

Keywords: SEER; colon cancer; liver metastasis; nomogram; prognosis.